您使用提示模式 关闭

SBIO - Invesco NASDAQ Biotech UCITS ETF Acc (USD) (IE00BQ70R696)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist,您可以随时了解投资信息,做出明智决策!

Watchlist
需要 访问
Cbonds API
Bring Market Data into Your Systems

Access ETF and Mutual Funds Data via API

  • Prices & NAV
  • Fund Structure
  • Inflows & dividends
 
(%)
IE00BQ70R696
SBIO ISIN
交易所交易基金 (ETF)
基金类型
Invesco
提供商
72,82 USD
每股资产净值 | 2026-09-14
2014-11-06
成立日期
股息的支付
CEOGMS
CFI
SBIO
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
NASDAQ Biotechnology Index
基准
0.4 %
总成本比率
494,01 百万 USD
基金资产总量 | 2026-09-14
494,01 百万 USD
股票类资产 | 2026-09-14
UCITS

7天试用体验

  • 获取数据库的完整在线访问权限
  • 使用我们强大的债券筛选器
  • 追踪来自400多个来源的债券价格
  • 智能投资组合监控

收益率 在 2026-09-14, London S.E. (USD)

  • YTD
    22,38 %
  • 1M
    3,07 %
  • 3M
    16,99 %
  • 6M
    22,11 %
  • 1Y
    45,2 %
  • 3Y
    71,8 %
  • 5Y
    -
  • 10Y
    -
按交换价格计算,包括收入支付

最新数据在
添加比较项目

报价 (SBIO)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

SBIO profile

The Invesco NASDAQ Biotech UCITS ETF Acc (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Invesco fund’s base currency is USD and the share class was registered 06.11.2014 with unique ISIN - IE00BQ70R696. Main exchange is London S.E. (USD) and ticker symbol is SBIO. The total expense ratio is 0.4%. The Invesco NASDAQ Biotech UCITS ETF Acc (USD) pays dividends 0 time(s) per year.

结构 SBIO 在 2026-09-14

证券
VERTEX PHARMACEUTICALS ORD 8,15%
AMGEN ORD 7,96%
GILEAD SCIENCES ORD 7,61%
REGENERON PHARMACEUTICALS ORD 5,48%
MODERNA ORD 3,9%
REVOLUTION MEDICINES ORD 2,92%
ALNYLAM PHARMACEUTICALS ORD 2,24%
BIOGEN ORD 2,15%
ILLUMINA ORD 2,11%
ROIVANT SCIENCES ORD 1,98%
ARGENX ADR REP ORD 1,83%
INSMED ORD 1,82%
ROYALTY PHARMA CL A ORD 1,75%
INCYTE ORD 1,64%
GUARDANT HEALTH ORD 1,49%
UNITED THERAPEUTICS ORD 1,43%
VIATRIS ORD 1,3%
MEDPACE HOLDINGS ORD 1,14%
ASCENDIS PHARMA ORD 1,09%
NEUROCRINE BIOSCIENCES ORD 1,06%
JAZZ PHARMACEUTICALS ORD 1,03%
SUMMIT THERAPEUTICS ORD 0,96%
BRIDGEBIO PHARMA ORD 0,95%
EXELIXIS ORD 0,95%
BIOMARIN PHARMACEUTICAL ORD 0,86%
HALOZYME THERAPEUTICS ORD 0,86%
MADRIGAL PHARMACEUTI ORD 0,83%
BEONE MEDICINES ADS REP ORD 0,78%
BIONTECH SE ADR 0,77%
ARROWHEAD PHARMACEUTICALS ORD 0,76%
AXSOME THERAPEUTICS ORD 0,75%
TEMPUS AI CL A ORD 0,73%
SANOFI 2 ADR REP ORD 0,68%
KRYSTAL BIOTECH ORD 0,67%
CYTOKINETICS ORD 0,66%
PROTAGONIST THERAPEUTICS ORD 0,64%
KYMERA THERAPEUTICS ORD 0,63%
PRAXIS PRECISION MEDICINES ORD 0,62%
IMMUNITYBIO ORD 0,59%
VAXCYTE ORD 0,58%
IONIS PHARMACEUTICALS ORD 0,57%
TWIST BIOSCIENCE ORD 0,56%
10X GENOMICS CL A ORD 0,55%
SPYRE THERAPEUTICS ORD 0,53%
IMMUNOVANT ORD 0,52%
ALKERMES ORD 0,51%
CARIS LIFE SCIENCES ORD 0,49%
RHYTHM PHARMACEUTICALS ORD 0,47%
ABIVAX SA ADR 0,44%
CG ONCOLOGY ORD 0,44%
SCHOLAR ROCK HOLDING ORD 0,42%
TRAVERE THERAPEUTICS ORD 0,41%
MIRUM PHARMACEUTICALS ORD 0,4%
ORUKA THERAPEUTICS ORD 0,39%
COGENT BIOSCIENCES ORD 0,38%
XENON PHARMACEUTICALS ORD 0,38%
LIGAND PHARMACEUTICALS ORD 0,38%
PTC THERAPEUTICS ORD 0,37%
AMNEAL PHARMACEUTICALS CL A ORD 0,37%
CRISPR THERAPEUTICS ORD 0,34%
ERASCA ORD 0,34%
EDGEWISE THERAPEUTICS ORD 0,32%
ACADIA PHARMACEUTICALS ORD 0,32%
DEFINIUM THERAPEUTICS ORD 0,29%
INDIVIOR PHARMACEUTICALS ORD 0,28%
IOVANCE BIOTHERAPEUTICS ORD 0,28%
RELAY THERAPEUTICS ORD 0,27%
ADAPTIVE BIOTECHNOLOGIES ORD 0,27%
AMYLYX PHARMACEUTICALS ORD 0,25%
TANGO THERAPEUTICS ORD 0,24%
KINIKSA PHARMACEUTICALS INT CL A ORD 0,24%
TARSUS PHARMACEUTICALS ORD 0,23%
ABCELLERA BIOLOGICS ORD 0,23%
DENALI THERAPEUTICS ORD 0,23%
IDEAYA BIOSCIENCES ORD 0,22%
ENLIVEN THERAPEUTICS ORD 0,22%
VERACYTE ORD 0,22%
GRAIL ORD 0,22%
DYNE THERAPEUTICS ORD 0,21%
ARCUTIS BIOTHERAPEUTICS ORD 0,2%
STRUCTURE THERAPEUTICS ADR 0,2%
UNIQURE ORD 0,19%
MBX BIOSCIENCES ORD 0,19%
PHARVARIS N V ORD 0,18%
NURIX THERAPEUTICS ORD 0,18%
DISC MEDICINE ORD 0,18%
NEWAMSTERDAM PHARMA ORD 0,18%
BEAM THERAPEUTICS ORD 0,17%
GENMAB ADR 0,17%
VERA THERAPEUTICS CL A ORD 0,16%
PRECIGEN ORD 0,16%
SUPERNUS PHARMACEUTICALS ORD 0,16%
HARMONY BIOSCIENCES HLDG ORD 0,16%
MINERALYS THERAPEUTICS ORD 0,16%
OCULAR THERAPEUTIX ORD 0,16%
TREVI THERAPEUTICS ORD 0,15%
SAREPTA THERAPEUTICS ORD 0,15%
ADMA BIOLOGICS ORD 0,14%
AURINIA PHARMACEUTICALS ORD 0,14%
RAPPORT THERAPEUTICS ORD 0,14%
Other - %

接入全球最大金融数据库

7天演示体验

公司代表免费使用

  • 体验先进的分析工具
  • 获取数据库的完整在线访问权限
  • 试用我们强大的债券筛选器
  • 追踪来自400多个来源的债券价格

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权